MCPsych
Funds integrated biological approaches for anhedonic depression through multidisciplinary teams that combine clinical and molecular insights.
Wellcome LeapCooperative agreement
About
MCPsych is Wellcome Leap’s $50 million program on anhedonic depression, designed to build an integrated model that links biology with measurable external signals across genes, molecules, cells, animal models, and humans. It sits in Wellcome Leap’s active portfolio and is already in execution, so the work is organized around selected teams rather than a standing open call. Susanne Ahmari, MD, PhD d…
BiotechMedtechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.